Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

The effect of myeloperoxidase isoforms on biophysical properties of red blood cells.

Shamova EV, Gorudko IV, Grigorieva DV, Sokolov AV, Kokhan AU, Melnikova GB, Yafremau NA, Gusev SA, Sveshnikova AN, Vasilyev VB, Cherenkevich SN, Panasenko OM.

Mol Cell Biochem. 2019 Nov 21. doi: 10.1007/s11010-019-03654-0. [Epub ahead of print]

PMID:
31754972
2.

[Neutrophils as a source of factors that increase the length of the inflammatory phase of wound healing in patients with type 2 diabetes mellitus].

Mikhalchik EV, Maximov DI, Ostrovsky EM, Yaskevich AV, Vlasova II, Vakhrusheva TV, Basyreva LY, Gusev AA, Kostevich VA, Gorbunov NP, Sokolov AV, Panasenko OM, Gusev SA.

Biomed Khim. 2018 Sep;64(5):433-438. doi: 10.18097/PBMC20186405433. Russian.

PMID:
30378560
3.

[Enzymatic and bactericidal activity of monomeric and dimeric forms of myeloperoxidase].

Vakhrusheva TV, Sokolov AV, Kostevich VA, Vasilyev VB, Panasenko OM.

Biomed Khim. 2018 Mar;64(2):175-182. doi: 10.18097/PBMC20186402175. Russian.

PMID:
29723147
4.

Neutrophil activation in response to monomeric myeloperoxidase.

Gorudko IV, Grigorieva DV, Sokolov AV, Shamova EV, Kostevich VA, Kudryavtsev IV, Syromiatnikova ED, Vasilyev VB, Cherenkevich SN, Panasenko OM.

Biochem Cell Biol. 2018 Oct;96(5):592-601. doi: 10.1139/bcb-2017-0290. Epub 2018 Mar 27.

PMID:
29585927
5.

[Exocytosis of myeloperoxidase from activated neutrophils in the presence of heparin].

Grigorieva DV, Gorudko IV, Kostevich VA, Vasilyev VB, Cherenkevich SN, Panasenko OM, Sokolov AV.

Biomed Khim. 2018 Jan;64(1):16-22. doi: 10.18097/PBMC20186401016. Russian.

PMID:
29460830
6.

Enzymatic and bactericidal activity of myeloperoxidase in conditions of halogenative stress.

Vakhrusheva TV, Grigorieva DV, Gorudko IV, Sokolov AV, Kostevich VA, Lazarev VN, Vasilyev VB, Cherenkevich SN, Panasenko OM.

Biochem Cell Biol. 2018 Oct;96(5):580-591. doi: 10.1139/bcb-2017-0292. Epub 2018 Feb 2.

PMID:
29394490
7.

Capacity of ceruloplasmin to scavenge products of the respiratory burst of neutrophils is not altered by the products of reactions catalyzed by myeloperoxidase.

Sokolov AV, Kostevich VA, Varfolomeeva EY, Grigorieva DV, Gorudko IV, Kozlov SO, Kudryavtsev IV, Mikhalchik EV, Filatov MV, Cherenkevich SN, Panasenko OM, Arnhold J, Vasilyev VB.

Biochem Cell Biol. 2018 Aug;96(4):457-467. doi: 10.1139/bcb-2017-0277. Epub 2018 Jan 25.

PMID:
29370542
8.

[The role of neutrophil myeloperoxidase in the development of inflammation after thermal skin burns].

Mikhalchik EV, Budkevich LI, Piterskaya YA, Penkov LY, Astamirova TS, Smolina NV, Vakhrusheva TV, Panasenko OM.

Biomed Khim. 2016 Jul;62(5):584-587. doi: 10.18097/PBMC20166205584. Russian.

PMID:
27797335
9.

Myeloperoxidase Stimulates Neutrophil Degranulation.

Grigorieva DV, Gorudko IV, Sokolov AV, Kostevich VA, Vasilyev VB, Cherenkevich SN, Panasenko OM.

Bull Exp Biol Med. 2016 Aug;161(4):495-500. doi: 10.1007/s10517-016-3446-7. Epub 2016 Sep 6.

PMID:
27597056
10.

[Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease].

Grigorieva DV, Gorudko IV, Kostevich VA, Sokolov AV, Buko IV, Vasilyev VB, Polonetsky LZ, Panasenko OM, Cherenkevich SN.

Biomed Khim. 2016 Mar;62(3):318-24. doi: 10.18097/PBMC20166203318. Russian.

PMID:
27420626
11.

Binding of human myeloperoxidase to red blood cells: Molecular targets and biophysical consequences at the plasma membrane level.

Gorudko IV, Sokolov AV, Shamova EV, Grigorieva DV, Mironova EV, Kudryavtsev IV, Gusev SA, Gusev AA, Chekanov AV, Vasilyev VB, Cherenkevich SN, Panasenko OM, Timoshenko AV.

Arch Biochem Biophys. 2016 Feb 1;591:87-97. doi: 10.1016/j.abb.2015.12.007. Epub 2015 Dec 20.

PMID:
26714302
12.

Kinetic method for assaying the halogenating activity of myeloperoxidase based on reaction of celestine blue B with taurine halogenamines.

Sokolov AV, Kostevich VA, Kozlov SO, Donskyi IS, Vlasova II, Rudenko AO, Zakharova ET, Vasilyev VB, Panasenko OM.

Free Radic Res. 2015 Jun;49(6):777-89. doi: 10.3109/10715762.2015.1017478. Epub 2015 Mar 20.

PMID:
25790937
13.

Interaction of ceruloplasmin with eosinophil peroxidase as compared to its interplay with myeloperoxidase: Reciprocal effect on enzymatic properties.

Sokolov AV, Kostevich VA, Zakharova ET, Samygina VR, Panasenko OM, Vasilyev VB.

Free Radic Res. 2015 Jun;49(6):800-11. doi: 10.3109/10715762.2015.1005615. Epub 2015 Mar 11.

PMID:
25762223
14.

Pluronics suppress association of low-density lipoproteins inducing atherogenesis.

Mel'nichenko AA, Aksenov DV, Panasenko OM, Yaroslavov AA, Sobenin IA, Orehov AN.

Bull Exp Biol Med. 2014 Mar;156(5):631-4. doi: 10.1007/s10517-014-2412-5. Epub 2014 Mar 25.

PMID:
24770745
15.

Proatherogenic modification of LDL by surface-bound myeloperoxidase.

Sokolov AV, Kostevich VA, Runova OL, Gorudko IV, Vasilyev VB, Cherenkevich SN, Panasenko OM.

Chem Phys Lipids. 2014 May;180:72-80. doi: 10.1016/j.chemphyslip.2014.02.006. Epub 2014 Mar 11.

PMID:
24631066
16.

Hypochlorous acid as a precursor of free radicals in living systems.

Panasenko OM, Gorudko IV, Sokolov AV.

Biochemistry (Mosc). 2013 Dec;78(13):1466-89. doi: 10.1134/S0006297913130075. Review.

17.

[Human serum albumin modified under oxidative/halogenative stress enhances luminol-dependent chemiluminescence of human neutrophils].

Mikhal'chik EV, Smolina NV, Astamirova TC, Gorudko IV, Grigor'eva DV, Ivanov VA, Sokolov AV, Kostevich VA, Cherenkevich SN, Panasenko OM.

Biofizika. 2013 Jul-Aug;58(4):681-9. Russian.

PMID:
24455888
18.

Hypohalous acid-modified human serum albumin induces neutrophil NADPH oxidase activation, degranulation, and shape change.

Gorudko IV, Grigorieva DV, Shamova EV, Kostevich VA, Sokolov AV, Mikhalchik EV, Cherenkevich SN, Arnhold J, Panasenko OM.

Free Radic Biol Med. 2014 Mar;68:326-34. doi: 10.1016/j.freeradbiomed.2013.12.023. Epub 2013 Dec 30.

PMID:
24384524
19.

Myeloperoxidase modulates human platelet aggregation via actin cytoskeleton reorganization and store-operated calcium entry.

Gorudko IV, Sokolov AV, Shamova EV, Grudinina NA, Drozd ES, Shishlo LM, Grigorieva DV, Bushuk SB, Bushuk BA, Chizhik SA, Cherenkevich SN, Vasilyev VB, Panasenko OM.

Biol Open. 2013 Jul 26;2(9):916-23. doi: 10.1242/bio.20135314. eCollection 2013.

20.

Measurement of plasma hemoglobin peroxidase activity.

Grigorieva DV, Gorudko IV, Sokolov AV, Kosmachevskaya OV, Topunov AF, Buko IV, Konstantinova EE, Cherenkevich SN, Panasenko OM.

Bull Exp Biol Med. 2013 May;155(1):118-21.

PMID:
23667888
21.

Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity.

Korotaeva A, Samoilova E, Pavlunina T, Panasenko OM.

Chem Phys Lipids. 2013 Feb-Mar;167-168:51-6. doi: 10.1016/j.chemphyslip.2013.02.004. Epub 2013 Feb 21.

PMID:
23438648
22.

Functional activity of neutrophils in diabetes mellitus and coronary heart disease: role of myeloperoxidase in the development of oxidative stress.

Gorudko IV, Kostevich VA, Sokolov AV, Shamova EV, Buko IV, Konstantinova EE, Vasiliev VB, Cherenkevich SN, Panasenko OM.

Bull Exp Biol Med. 2012 Nov;154(1):23-6.

PMID:
23330081
23.

Pluronic block copolymers inhibit low density lipoprotein self-association.

Melnichenko AA, Aksenov DV, Myasoedova VA, Panasenko OM, Yaroslavov AA, Sobenin IA, Bobryshev YV, Orekhov AN.

Lipids. 2012 Oct;47(10):995-1000. Epub 2012 Jul 14.

PMID:
22797973
24.

[Glutathione-dependent regulation of platelet aggregation with neutrophils and tumor cells].

Gorudko IV, Shamova EV, Shishlo LM, Mukhortova AV, Prokhorova VI, Panasenko OM, Gusev SA, Cherenkevich SN.

Biofizika. 2012 Jan-Feb;57(1):93-8. Russian.

PMID:
22567914
25.

Protection of ceruloplasmin by lactoferrin against hydroxyl radicals is pH dependent.

Sokolov AV, Solovyov KV, Kostevich VA, Chekanov AV, Pulina MO, Zakharova ET, Shavlovski MM, Panasenko OM, Vasilyev VB.

Biochem Cell Biol. 2012 Jun;90(3):397-404. doi: 10.1139/o2012-004. Epub 2012 Mar 7.

PMID:
22397552
26.

[A search for new markers of oxidative stress in brain ischemia for the optimization of treatment approaches].

Baranova OA, Chekanov AV, Karneev AN, Mironova OP, Miachin IV, Panasenko OM, Solov'eva EIu, Fedin AI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(12):25-31. Russian.

PMID:
22433805
27.

Revealing binding sites for myeloperoxidase on the surface of human low density lipoproteins.

Sokolov AV, Chekanov AV, Kostevich VA, Aksenov DV, Vasilyev VB, Panasenko OM.

Chem Phys Lipids. 2011 Jan;164(1):49-53. doi: 10.1016/j.chemphyslip.2010.10.004. Epub 2010 Nov 3.

PMID:
21055395
28.

[Halogenizing stress and its biomarkers].

Panasenko OM, Sergienko VI.

Vestn Ross Akad Med Nauk. 2010;(1):27-39. Review. Russian.

PMID:
20408436
29.

Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin.

Sokolov AV, Ageeva KV, Cherkalina OS, Pulina MO, Zakharova ET, Prozorovskii VN, Aksenov DV, Vasilyev VB, Panasenko OM.

Chem Phys Lipids. 2010 May;163(4-5):347-55. doi: 10.1016/j.chemphyslip.2010.02.002. Epub 2010 Feb 16.

PMID:
20167214
30.

[New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma].

Gorudko IV, Cherkalina OS, Sokolov AV, Pulina MO, Zakharova ET, Vasil'ev VB, Cherenkevich SN, Panasenko OM.

Bioorg Khim. 2009 Sep-Oct;35(5):629-39. Russian.

PMID:
19915640
31.

Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other.

Sokolov AV, Ageeva KV, Pulina MO, Cherkalina OS, Samygina VR, Vlasova II, Panasenko OM, Zakharova ET, Vasilyev VB.

Free Radic Res. 2008 Nov;42(11-12):989-98. doi: 10.1080/10715760802566574.

PMID:
19031316
32.

[A study of the effect of ceruloplasmin and lactoferrin on the chlorination activity of leukocytic myeloperoxidase using the chemiluminescence method].

Panasenko OM, Chekanov AV, Vlasova II, Sokolov AV, Ageeva KV, Pulina MO, Cherkalina OS, Vasil'ev VB.

Biofizika. 2008 Jul-Aug;53(4):573-81. Russian.

PMID:
18819272
33.

Role of myeloperoxidase-mediated modification of human blood lipoproteins in atherosclerosis development.

Panasenko OM, Vakhrusheva TV, Vlasova II, Chekanov AV, Baranov YV, Sergienko VI.

Bull Exp Biol Med. 2007 Sep;144(3):428-31.

PMID:
18457050
34.

Mechanisms of oxidative modification of low density lipoproteins under conditions of oxidative and carbonyl stress.

Lankin VZ, Tikhaze AK, Kapel'ko VI, Shepel'kova GS, Shumaev KB, Panasenko OM, Konovalova GG, Belenkov YN.

Biochemistry (Mosc). 2007 Oct;72(10):1081-90. Review.

35.

Oxidation-induced aggregation of LDL increases their uptake by smooth muscle cells from human aorta.

Panasenko OM, Mel'nichenko AA, Aksenov DV, Tertov VV, Kaplun VV, Sobenin IA, Orekhov AN.

Bull Exp Biol Med. 2007 Feb;143(2):200-3.

PMID:
17970201
36.

Influence of chloride on modification of unsaturated phosphatidylcholines by the myeloperoxidase/hydrogen peroxide/bromide system.

Panasenko OM, Vakhrusheva T, Tretyakov V, Spalteholz H, Arnhold J.

Chem Phys Lipids. 2007 Sep-Oct;149(1-2):40-51. Epub 2007 May 18.

PMID:
17604010
37.

[A comparative spin trapping study of hypobromous and hypochlorous acids interaction with tert-butyl hydroperoxide].

Chekanov AV, Osipov AN, Vladimirov IuA, Sergienko VI, Panasenko OM.

Biofizika. 2007 Jan-Feb;52(1):5-13. Russian.

PMID:
17348389
38.

pH-dependent regulation of myeloperoxidase activity.

Vlasova II, Arnhold J, Osipov AN, Panasenko OM.

Biochemistry (Mosc). 2006 Jun;71(6):667-77.

PMID:
16827659
39.

Proteolysis of apoprotein B-100 impairs its topography on LDL surface and reduces LDL association resistance.

Panasenko OM, Aksenov DV, Mel'nichenko AA, Suprun IV, Yanushevskaya EV, Vlasik TN, Sobenin IA, Orekhov AN.

Bull Exp Biol Med. 2005 Nov;140(5):521-5.

PMID:
16758614
40.

Leukocytic myeloperoxidase-mediated formation of bromohydrins and lysophospholipids from unsaturated phosphatidylcholines.

Panasenko OM, Spalteholz H, Schiller J, Arnhold J.

Biochemistry (Mosc). 2006 May;71(5):571-80.

PMID:
16732739
41.

Phospholipid hydrolysis with phospholipases A2 and C impairs apolipoprotein B-100 conformation on the surface of low density lipoproteins by reducing their association resistance.

Aksenov DV, Mel'nichenko AA, Suprun IV, Yanushevskaya EV, Vlasik TN, Sobenin IA, Panasenko OM, Orekhov AN.

Bull Exp Biol Med. 2005 Oct;140(4):419-22.

PMID:
16671570
42.

Generation of free radicals during decomposition of hydroperoxide in the presence of myeloperoxidase or activated neutrophils.

Panasenko OM, Chekanov AV, Arnhold J, Sergienko VI, Osipov AN, Vladimirov YA.

Biochemistry (Mosc). 2005 Sep;70(9):998-1004.

PMID:
16266270
43.

Desialylation decreases the resistance of apo B-containing lipoproteins to aggregation and increases their atherogenic potential.

Mel'nichenko AA, Tertov VV, Ivanova OA, Aksenov DV, Sobenin IA, Popov EV, Kaplun VV, Suprun IV, Panasenko OM, Orekhov AN.

Bull Exp Biol Med. 2005 Jul;140(1):51-4.

PMID:
16254619
44.

[A comparative study of the lipid phase in native and circulating multiple-modified low-density lipoproteins of human blood by the use of the spin probe method].

Vakhrusheva TV, Panasenko OM, Mel'nichenko AA, Orekhov AN.

Biofizika. 2005 Jul-Aug;50(4):652-9. Russian.

PMID:
16212056
45.

Formation of reactive halide species by myeloperoxidase and eosinophil peroxidase.

Spalteholz H, Panasenko OM, Arnhold J.

Arch Biochem Biophys. 2006 Jan 15;445(2):225-34. Epub 2005 Jul 28.

PMID:
16111649
46.

[Low-density lipoproteins with different capacity for aggregation].

Dobretsov GE, Gularian SK, Panasenko OM, Orekhov AN, Isakova SI.

Biofizika. 2005 Mar-Apr;50(2):277-80. Russian.

PMID:
15856985
47.

[The interaction of hypochlorite with fatty acid hydroperoxides results in the generation of free radicals].

Chekanov AV, Panasenko OM, Osipov AN, Matveeva NS, Kazarinov KD, Vladimirov IuA, Sergienko VI.

Biofizika. 2005 Jan-Feb;50(1):13-9. Russian.

PMID:
15759498
48.

Resistance of native and circulating modified low-density lipoproteins in human blood to association.

Suprun IV, Mel'nichenko AA, Sobenin IA, Panasenko OM, Orekhov AN.

Bull Exp Biol Med. 2004 Oct;138(4):380-3.

PMID:
15665950
49.

Low ionic strength promotes association of circulating modified LDL in human blood.

Panasenko OM, Suprun IV, Mel'nichenko AA, Sobenin IA, Orekhov AN.

Bull Exp Biol Med. 2004 Sep;138(3):248-50.

PMID:
15665915
50.

Antigenic differences between apo-B in native and circulating modified low-density lipoproteins.

Suprun IV, Mel'nichenko AA, Yanushevskaya EV, Vlasik TN, Sobenin IA, Panasenko OM, Orekhov AN.

Bull Exp Biol Med. 2004 Jul;138(1):42-4.

PMID:
15514719

Supplemental Content

Loading ...
Support Center